Chinonyerem Ogadi Iheanacho, Okechukwu Harrison Enechukwu, Chinelo Nneka Aguiyi-Ikeanyi
{"title":"尼日利亚COVID-19疫苗的风险认知和可接受性","authors":"Chinonyerem Ogadi Iheanacho, Okechukwu Harrison Enechukwu, Chinelo Nneka Aguiyi-Ikeanyi","doi":"10.4274/tjps.galenos.2021.75710","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Vaccines are anticipated to control the ongoing coronavirus disease-2019 (COVID-19) pandemic, however, their acceptance is critical for the desired benefit. This study assessed risk perceptions of COVID-19, acceptability of its vaccine and socio-demographic associations of its acceptability in Nigeria.</p><p><strong>Materials and methods: </strong>A cross-sectional web-based study was conducted among 420 participants in Nigeria's six geopolitical regions, using a three-part questionnaire. The questionnaire link was distributed <i>via</i> snowball method to consenting participants through online platforms. Study outcome measures were acceptance of COVID-19 vaccine, and risk perception of COVID-19 by study participants. Descriptive and inferential statistics were performed using Microsoft Excel and SPSS version 24. <i>p</i> values ≤0.05 were considered statistically significant.</p><p><strong>Results: </strong>A total of 410 respondents participated in the study and high-risk perception of severe acute respiratory syndrome-coronavirus-2 infection (COVID-19) was seen in 127 (66.1%) respondents. Vaccine acceptance was high in 233 (56.8%) respondents and was significantly associated with geo-political region (<i>p</i>=0.028). A moderate positive relationship (r: 0.3) was found between risk perception and acceptability of COVID-19 vaccine and the correlation was statistically significant (<i>p</i>=0.000).</p><p><strong>Conclusion: </strong>High-risk perception of COVID-19 was found in over half of the respondents, and COVID-19 vaccine acceptance rate was a little more than 50%. However, the study noted regional association with vaccine acceptance among study participants. Therefore, strategic and targeted messaging on vaccine acceptance should be prioritized by stakeholders, to ensure successful vaccine implementation.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 6","pages":"686-693"},"PeriodicalIF":1.8000,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780578/pdf/TJPS-19-686.pdf","citationCount":"3","resultStr":"{\"title\":\"Risk Perception and Acceptability of the COVID-19 Vaccine in Nigeria.\",\"authors\":\"Chinonyerem Ogadi Iheanacho, Okechukwu Harrison Enechukwu, Chinelo Nneka Aguiyi-Ikeanyi\",\"doi\":\"10.4274/tjps.galenos.2021.75710\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Vaccines are anticipated to control the ongoing coronavirus disease-2019 (COVID-19) pandemic, however, their acceptance is critical for the desired benefit. This study assessed risk perceptions of COVID-19, acceptability of its vaccine and socio-demographic associations of its acceptability in Nigeria.</p><p><strong>Materials and methods: </strong>A cross-sectional web-based study was conducted among 420 participants in Nigeria's six geopolitical regions, using a three-part questionnaire. The questionnaire link was distributed <i>via</i> snowball method to consenting participants through online platforms. Study outcome measures were acceptance of COVID-19 vaccine, and risk perception of COVID-19 by study participants. Descriptive and inferential statistics were performed using Microsoft Excel and SPSS version 24. <i>p</i> values ≤0.05 were considered statistically significant.</p><p><strong>Results: </strong>A total of 410 respondents participated in the study and high-risk perception of severe acute respiratory syndrome-coronavirus-2 infection (COVID-19) was seen in 127 (66.1%) respondents. Vaccine acceptance was high in 233 (56.8%) respondents and was significantly associated with geo-political region (<i>p</i>=0.028). A moderate positive relationship (r: 0.3) was found between risk perception and acceptability of COVID-19 vaccine and the correlation was statistically significant (<i>p</i>=0.000).</p><p><strong>Conclusion: </strong>High-risk perception of COVID-19 was found in over half of the respondents, and COVID-19 vaccine acceptance rate was a little more than 50%. However, the study noted regional association with vaccine acceptance among study participants. Therefore, strategic and targeted messaging on vaccine acceptance should be prioritized by stakeholders, to ensure successful vaccine implementation.</p>\",\"PeriodicalId\":23378,\"journal\":{\"name\":\"Turkish Journal of Pharmaceutical Sciences\",\"volume\":\"19 6\",\"pages\":\"686-693\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2022-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780578/pdf/TJPS-19-686.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkish Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/tjps.galenos.2021.75710\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/tjps.galenos.2021.75710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 3
摘要
目的:疫苗有望控制正在进行的冠状病毒病-2019 (COVID-19)大流行,然而,疫苗的接受对预期的效益至关重要。本研究评估了对COVID-19的风险认知、疫苗的可接受性以及尼日利亚对其可接受性的社会人口关联。材料和方法:在尼日利亚六个地缘政治地区的420名参与者中进行了一项基于网络的横断面研究,使用了三部分问卷。问卷链接通过滚雪球的方式通过网络平台分发给同意的参与者。研究结果测量是研究参与者对COVID-19疫苗的接受程度和对COVID-19的风险认知。采用Microsoft Excel和SPSS version 24进行描述性和推断性统计。P值≤0.05认为有统计学意义。结果:共有410名调查对象参与了本研究,其中127名(66.1%)存在严重急性呼吸综合征-冠状病毒-2感染(COVID-19)高危认知。233名应答者(56.8%)的疫苗接受度较高,且与地缘政治区域显著相关(p=0.028)。风险认知与COVID-19疫苗接受度呈中等正相关(r: 0.3),相关性有统计学意义(p=0.000)。结论:半数以上的被调查者对新冠肺炎有高危认知,疫苗接种率略高于50%。然而,该研究指出了研究参与者对疫苗接受程度的区域关联。因此,利益攸关方应优先考虑关于疫苗接受的战略性和有针对性的信息传递,以确保疫苗的成功实施。
Risk Perception and Acceptability of the COVID-19 Vaccine in Nigeria.
Objectives: Vaccines are anticipated to control the ongoing coronavirus disease-2019 (COVID-19) pandemic, however, their acceptance is critical for the desired benefit. This study assessed risk perceptions of COVID-19, acceptability of its vaccine and socio-demographic associations of its acceptability in Nigeria.
Materials and methods: A cross-sectional web-based study was conducted among 420 participants in Nigeria's six geopolitical regions, using a three-part questionnaire. The questionnaire link was distributed via snowball method to consenting participants through online platforms. Study outcome measures were acceptance of COVID-19 vaccine, and risk perception of COVID-19 by study participants. Descriptive and inferential statistics were performed using Microsoft Excel and SPSS version 24. p values ≤0.05 were considered statistically significant.
Results: A total of 410 respondents participated in the study and high-risk perception of severe acute respiratory syndrome-coronavirus-2 infection (COVID-19) was seen in 127 (66.1%) respondents. Vaccine acceptance was high in 233 (56.8%) respondents and was significantly associated with geo-political region (p=0.028). A moderate positive relationship (r: 0.3) was found between risk perception and acceptability of COVID-19 vaccine and the correlation was statistically significant (p=0.000).
Conclusion: High-risk perception of COVID-19 was found in over half of the respondents, and COVID-19 vaccine acceptance rate was a little more than 50%. However, the study noted regional association with vaccine acceptance among study participants. Therefore, strategic and targeted messaging on vaccine acceptance should be prioritized by stakeholders, to ensure successful vaccine implementation.